Global HIV-1 Screening Tests Market Growth (Status and Outlook) 2025-2031

Global HIV-1 Screening Tests Market Growth (Status and Outlook) 2025-2031

The global HIV-1 Screening Tests market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for HIV-1 Screening Tests is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for HIV-1 Screening Tests is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for HIV-1 Screening Tests is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key HIV-1 Screening Tests players cover Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (US), Thermo-Fisher Scientific Inc (US), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “HIV-1 Screening Tests Industry Forecast” looks at past sales and reviews total world HIV-1 Screening Tests sales in 2024, providing a comprehensive analysis by region and market sector of projected HIV-1 Screening Tests sales for 2025 through 2031. With HIV-1 Screening Tests sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HIV-1 Screening Tests industry.

This Insight Report provides a comprehensive analysis of the global HIV-1 Screening Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on HIV-1 Screening Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HIV-1 Screening Tests market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HIV-1 Screening Tests and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HIV-1 Screening Tests.

This report presents a comprehensive overview, market shares, and growth opportunities of HIV-1 Screening Tests market by product type, application, key players and key regions and countries.

Segmentation by Type:
ELISA
Rapid Tests
Home Access Dried Blood Spot

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siemens AG (Germany)
Roche Diagnostics (Switzerland)
Abbott Laboratories (U.S)
Danaher Corporation (US)
Thermo-Fisher Scientific Inc (US)
Merck KGaA (Germany)
Becton, Dickinson and Company (US)
Hologic, Inc (US)
Alere Inc (US)
Bio-Rad Laboratories (US)

Please note: The report will take approximately 2 business days to prepare and deliver.